31 first line therapy: the role of biomarkers and nccn guidelines
Published 1 year ago • 377 plays • Length 19:13Download video MP4
Download video MP3
Similar videos
-
0:54
the role of biomarkers in gastric cancers
-
58:22
32 first line therapy for her2 gea
-
46:59
21 principles of biomarker testing: part 1 tissue testing
-
30:11
20 years of clinical practice guidelines: nccn guidelines and treatment decisions
-
1:09:09
35 first line therapy for her2-, pdl1-, cldn18.2- gea
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
51:14
stomach cancer webinar: molecular biomarkers, presented by samuel klempner, md
-
22:01
pipac for gastric cancer with yanghee woo, m.d.
-
13:38
neoadjuvant chemotherapy for gastric cancer patients
-
1:55
dr. ku on combinations and sequencing of treatments for gastric cancer
-
28:40
29 first line chemotherapy
-
31:51
30 first line chemotherapy doublet vs triplet
-
18:07
organization overview: hope for stomach cancer
-
1:07
claudin 18.2: a biomarker for gastric cancer
-
1:00:39
stomach cancer q&a with yelena janjigian, m.d., chief of gastrointestinal oncology
-
22:39
gastric cancer: update on first-line therapies
-
7:26
is frontline io therapy appropriate in gastric cancer?
-
1:44
evolving nccn guidelines for mpns
-
1:38:03
clinical trials updates for gastric cancer patients